Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | WNT3A | P56704 | 1/20 | 0.39 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.39 |
| ▸ | CSF1R | P07333 | 1/20 | 0.39 |
| ▸ | DAPK1 | P53355 | 1/20 | 0.39 |
| ▸ | KCNH2 | Q12809 | 1/20 | 0.39 |
| ▸ | PIK3CA | P42336 | 3/20 | 0.39 |
| ▸ | PIK3R1 | P27986 | 2/20 | 0.39 |
| ▸ | MTOR | P42345 | 2/20 | 0.39 |
| ▸ | AOC3 | Q16853 | 1/20 | 0.38 |
| ▸ | CYP1A2 | P05177 | 2/20 | 0.37 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.37 |
| ▸ | HSD17B10 | Q99714 | 2/20 | 0.37 |
| ▸ | POLB | P06746 | 1/20 | 0.37 |
| ▸ | HPGD | P15428 | 1/20 | 0.37 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.37 |
| ▸ | IKBKE | Q14164 | 1/20 | 0.37 |
| ▸ | TBK1 | Q9UHD2 | 1/20 | 0.37 |
| ▸ | GAA | P10253 | 1/20 | 0.37 |
| ▸ | DGAT1 | O75907 | 1/20 | 0.36 |
| ▸ | MAPT | P10636 | 2/20 | 0.36 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL28940962 | 0.77 | ALDH1A1 (0.55) | ALDH1A1AOC3CYP1A2KDM4EHSD17B10 | |
| SCHEMBL31159357 | 0.74 | MTOR (0.34) | PIK3CAPIK3R1MTORJAK2JAK1 | |
| SCHEMBL27766592 | 0.70 | ALDH1A1 (0.55) | ALDH1A1AOC3CYP1A2KDM4EHSD17B10 | |
| SCHEMBL28528175 | 0.70 | ADK (0.47) | ALDH1A1HPGDIKBKETBK1JAK2 | |
| SCHEMBL31104821 | 0.69 | PIK3CA (0.49) | ALDH1A1PIK3CAPIK3R1MTORCYP1A2 | |
| SCHEMBL31104349 | 0.69 | MAPT (0.46) | WNT3AALDH1A1AOC3CYP1A2KDM4E | |
| SCHEMBL31104651 | 0.69 | MAPT (0.46) | WNT3AALDH1A1AOC3CYP1A2KDM4E | |
| SCHEMBL31104807 | 0.68 | GRM1 (0.38) | WNT3AALDH1A1CSF1RDAPK1KCNH2 | |
| SCHEMBL2852915 | 0.67 | ALDH1A1 (0.55) | ALDH1A1AOC3CYP1A2KDM4EHSD17B10 | |
| SCHEMBL31104808 | 0.67 | ALDH1A1 (0.40) | WNT3AALDH1A1AOC3CYP1A2KDM4E |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20250091997-A1 | COMPOSITIONS AND METHODS FOR MAKING AND USING SMALL MOLECULES FOR TUBULIN-TARGETED THERAPY IN THE TREATMENT OF CANCERS AND RELATED CONDITIONS | REGLAGENE, INC. | 2025-03-20 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20250091997-A1 | COMPOSITIONS AND METHODS FOR MAKING AND USING SMALL MOLECULES FOR TUBULIN-TARGETED THERAPY IN THE TREATMENT OF CANCERS AND RELATED CONDITIONS | TUBB3, TUBB1, TUBB6 | WNT3A 3022/4885ALDH1A1 3722/4885CSF1R 2700/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.